Approaches To Improve Adherence To Pharmacotherapy In Patients With Schizophrenia
Research Summary | April 1, 2016
Not a member? Sign up for free!
Join us as we continue our efforts towards improving the future of mental health care through information, discussion, and collaboration. Sign up today for instant access to all PsychU offerings. Membership is free!
Key Messages For patients with schizophrenia, nonadherence to prescribed medications increases the risk of relapse and hospitalization. Multidisciplinary treatment team approaches, such as assertive community treatment (ACT) teams, may help to improve treatment adherence. Various patient-specific factors, such as stigma related to taking medications and lack of awareness/denial of illness, may contribute to nonadherence. The…
PsychU offers private, personalized educational programs, both online and in-person, on a range of topics, including: schizophrenia, major depressive disorder, bipolar disorder, care coordination, quality standards, and health care policy.
Any PsychU member can request a presentation for their region or organization for free.
This link will take you outside of the PsychU community website.
By selecting continue, you will be leaving PsychU. The destination site to which you will be redirected is not controlled or endorsed by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and / or Lundbeck, LLC.